4/16
07:00 am
igc
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
Medium
Report
IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two
4/9
09:00 am
igc
IGC Pharma Adds Advisor in Artificial Intelligence
High
Report
IGC Pharma Adds Advisor in Artificial Intelligence
3/26
03:00 pm
igc
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
Low
Report
IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock
3/20
11:00 am
igc
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
Medium
Report
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
3/20
07:00 am
igc
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
Low
Report
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
3/12
03:00 pm
igc
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
Low
Report
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
2/28
01:00 pm
igc
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
Medium
Report
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
2/23
12:01 pm
igc
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target
Medium
Report
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a “Buy” Recommendation and $3.00 Price Target
4/18
06:04 am
igc
Form S-3 IGC Pharma, Inc.
High
Report
Form S-3 IGC Pharma, Inc.
4/5
11:34 am
igc
Form 8-K IGC Pharma, Inc. For: Mar 20
Medium
Report
Form 8-K IGC Pharma, Inc. For: Mar 20
3/28
06:03 am
igc
Form 8-K IGC Pharma, Inc. For: Mar 22
Low
Report
Form 8-K IGC Pharma, Inc. For: Mar 22
3/22
06:01 am
igc
Form 424B5 IGC Pharma, Inc.
High
Report
Form 424B5 IGC Pharma, Inc.
3/22
06:01 am
igc
Form 8-K IGC Pharma, Inc. For: Mar 19
High
Report
Form 8-K IGC Pharma, Inc. For: Mar 19
3/18
03:52 pm
igc
Form 4 IGC Pharma, Inc. For: Mar 13 Filed by: MUKUNDA RAM
Low
Report
Form 4 IGC Pharma, Inc. For: Mar 13 Filed by: MUKUNDA RAM
3/15
09:27 pm
igc
Form 4 IGC Pharma, Inc. For: Mar 13 Filed by: GRIMALDI CLAUDIA
Low
Report
Form 4 IGC Pharma, Inc. For: Mar 13 Filed by: GRIMALDI CLAUDIA
3/15
09:10 pm
igc
Form 4 IGC Pharma, Inc. For: Mar 13 Filed by: PRINS RICHARD K
Low
Report
Form 4 IGC Pharma, Inc. For: Mar 13 Filed by: PRINS RICHARD K
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
6/13
IGC to Participate in Arizona’s Industrial Hemp Program
44.2%
9/19
IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 study
8.3%
3/16
Form 8-K India Globalization Capi For: Mar 13
4.2%
11/6
India Globalization Capital Quarterly Loss Per Share $0.03 [Reuters]
3.3%
10/4
IGC Opens Marketing and Research Hub in Colombia
3.1%
7/26
Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group
2.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register